000			01686nam a22002777a 4500
001			D0001B001256
003			DOH
005			20210123114310.0
008			210123b ||||| |||| 00| 0 eng d
020			_a1586033344
040			_erda
245	0	0	_aDrugs and money : _bprices, affordability and cost containment / _cEdited by M.N.G. Dukes [and four others]
260			_aAmsterdam : _bIOS Press, _c© 2003
300			_aVI, 152 pages.
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarier _avolume
501			_aPublished on behalf of the World Health Organization Regional Office for Europe by IOS Press -- Title page.
520	2		_aContent: 1. Scope of the problem. -- 2. Data needed for developing and monitoring policies. -- 3. Policy options for cost containment of pharmaceuticals -- 4. Methods for monitoring and evaluating processes and outcomes. -- 5. Making use of economic evaluation. -- 6. Measures relating to use of drug subsidy lists and to regulation. -- 7. Experiences with budgets. -- 8. Experiences with reference pricing. -- 9. Experiences with patient charges. -- 10. Switching to non-prescription status. -- 11. Experiences with generics. -- 12. Experiences with pharmacy benefit management programmes in the USA. -- 13. Experiences with professional education. -- 14. Providing affordable medicines in transitional countries. -- 15. Access to medicines in low-income countries.
700	1		_aDukes, M.N. Graham
700	1		_aGraham, M.N.
700	1		_aJoncheere, Kees de
700	1		_aRietveld, Ad H.
856			_uhttps://www.euro.who.int/__data/assets/pdf_file/0011/96446/e79122.pdf
942			_2nlm _cBK
999			_c2496 _d2496